Evidence map›Paper›PMID 22922783›Full record

ArticleNature neuroscience2012

Positive modulation of a Cys-loop acetylcholine receptor by an auxiliary transmembrane subunit.

Thomas Boulin, Georgia Rapti, Luis Briseño-Roa, Christian Stigloher, Janet E Richmond, Pierre Paoletti, Jean-Louis Bessereau

Abstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An extracellular scaffolding complex confers unusual rectification upon an ionotropic acetylcholine receptor inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Regulation of GABATrends in neurosciences · 2021
    Review
  12. Article
  13. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.International journal for parasitology. Drugs and drug resistance · 2020
    Review
  14. Article
  15. Hair cell α9α10 nicotinic acetylcholine receptor functional expression regulated by ligand binding and deafness gene products.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. The Claudin-like Protein HPO-30 Is Required to Maintain LAChRs at theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Thomas BoulinInstitut de Biologie de l'École Normale Supérieure, Département de Biologie, Paris, France. boulin@biologie.ens.fr
Georgia Rapti
Luis Briseño-Roa
Christian Stigloher
Janet E Richmond
Pierre Paoletti
Jean-Louis Bessereau
Centre National de la Recherche Scientifique · FRInstitut de Biologie de l'École Normale Supérieure · FRUniversity of Illinois Chicago · US

Funding

The role of tomosyn in synaptic transmission.R01MH073156 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RICHMOND, JANET E · 2006 to 2010
$2.0M
NIMH NIH HHS R01 MH073156
6 · The paper itself

Abstract

Auxiliary subunits regulate the trafficking, localization or gating kinetics of voltage- and ligand-gated ion channels by associating tightly and specifically with pore-forming subunits. However, no auxiliary subunits have been identified for members of the Cys-loop receptor superfamily. Here we identify MOLO-1, a positive regulator of levamisole-sensitive acetylcholine receptors (L-AChRs) at the Caenorhabditis elegans neuromuscular junction. MOLO-1 is a one-pass transmembrane protein that contains a single extracellular globular domain-the TPM domain, found in bacteria, plants and invertebrates, including nonvertebrate chordates. Loss of MOLO-1 impairs locomotion and renders worms resistant to the anthelmintic drug levamisole. In molo-1 mutants, L-AChR-dependent synaptic transmission is reduced by half, while the number and localization of receptors at synapses remain unchanged. In a heterologous expression system, MOLO-1 physically interacts with L-AChRs and directly enhances channel gating without affecting unitary conductance. The identification of MOLO-1 expands the mechanisms for generating functional and pharmacological diversity in the Cys-loop superfamily.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCholinergic AgonistsCysteine Loop Ligand-Gated Ion Channel ReceptorsDrug ResistanceIon Channel GatingIon ChannelsLevamisoleLocomotionMuscle ContractionMutationNeuromuscular JunctionProtein SubunitsReceptors, CholinergicSynaptic TransmissionCaenorhabditis elegans ProteinsCholinergic AgonistsCysteine Loop Ligand-Gated Ion Channel ReceptorsIon ChannelsLevamisolemolo-1 protein, C elegansProtein SubunitsReceptors, Cholinergic

Identifiers

PMID22922783
OpenAlexW2016293530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.